These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 9854612

  • 41. [Histochemical study of lipid metabolism of the lungs in experimental tuberculosis and its treatment].
    Bagirova IB.
    Probl Tuberk; 1978 Sep; (9):78-81. PubMed ID: 568264
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. The role of extrinsic and intrinsic factors in the evolution of the control of pulmonary surfactant maturation during development in the amniotes.
    Sullivan LC, Orgeig S, Daniels CB.
    Physiol Biochem Zool; 2003 Sep; 76(3):281-95. PubMed ID: 12905114
    [Abstract] [Full Text] [Related]

  • 45. Pulmonary surfactant transport in alveolar type II cells.
    Osanai K, Tsuchihara C, Hatta R, Oikawa T, Tsuchihara K, Iguchi M, Seki T, Takahashi M, Huang J, Toga H.
    Respirology; 2006 Jan; 11 Suppl():S70-3. PubMed ID: 16423277
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Surfactant catabolism.
    Ikegami M.
    Respirology; 2006 Jan; 11 Suppl():S24-7. PubMed ID: 16423266
    [Abstract] [Full Text] [Related]

  • 48. Inactivation of pulmonary surfactant by silicone oil in vitro and in ventilated immature rabbits.
    Stichtenoth G, Linderholm B, Almlén A, Björkman MH, Byman I, Nordling K, Robertson B, Johansson J, Herting E, Curstedt T.
    Crit Care Med; 2009 May; 37(5):1750-6. PubMed ID: 19325472
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Perfluorocarbons are taken up by isolated type II pneumocytes and influence its lipid synthesis and secretion.
    Rüdiger M, Wissel H, Ochs M, Burkhardt W, Proquitté H, Wauer RR, Stevens P, Rüstow B.
    Crit Care Med; 2003 Apr; 31(4):1190-6. PubMed ID: 12682492
    [Abstract] [Full Text] [Related]

  • 52. [A means of obtaining surface-active substance (surfactant) from atelectatic lobes or portions of the lungs].
    Triniak NG.
    Biull Eksp Biol Med; 1973 Jun; 75(6):121-3. PubMed ID: 4801359
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [Therapeutic pathomorphosis. Effect of immunostimulator levamisole on the morphology of specific inflammation under experimental conditions].
    Kireeva SG, Selitskaia RP.
    Arkh Patol; 1982 Jun; 44(11):38-43. PubMed ID: 7159236
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [A case of multi-drug resistant pulmonary tuberculosis after administration of standard anti-tuberculosis treatment for two times].
    Wakabayashi K, Yano S, Kobayashi K, Tokuda Y, Ikeda T, Ishikawa S, Takeyama H.
    Kekkaku; 2008 Jul; 83(7):513-7. PubMed ID: 18709969
    [Abstract] [Full Text] [Related]

  • 60. Pulmonary surfactant: determinations from lung extracts of patients receiving diethyl ether or halothane.
    Miller RN, Thomas PA.
    Anesthesiology; 1967 Jul; 28(6):1089-93. PubMed ID: 6054214
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.